More than 40,000 previously unknown gut microbes in African populations could completely change how medicines work for millions of people, according to scientists.
Biotech investors push to extend time before pills are subject to price negotiations
The fight over drug prices is far from over. Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — against allowing Medicare to negotiate drug